Gleason Score Evolution and the Effect on Prostate Cancer Outcomes

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Gleason grading is crucial for prostate cancer prognostication.
• Changes in grading guidelines may impact long-term outcome assessments.

Purpose of the Study:

• To evaluate the impact of revised Gleason grading on long-term outcomes in a prostatectomy cohort.
• To compare outcomes using contemporary versus historical Gleason scoring.

Main Methods:

• Retrospective analysis of 581 patients undergoing radical prostatectomy (1985-1995).
• Specimens were regraded according to current guidelines.
• Long-term follow-up (16.7 years) assessed biochemical failure, metastatic disease, and prostate cancer death.

Main Results:

• Revised Gleason grading shifted scores, with fewer patients in lower-risk groups (Gleason ≤6) and more in intermediate-risk groups (Gleason 7).
• Biochemical failure, metastatic disease, and prostate cancer death decreased across all risk groups with revised grading.
• The current grading system demonstrates a clear increase in adverse outcomes with each successive grade group.

Conclusions:

• Revised Gleason scores enhance the prediction of long-term outcomes for prostate cancer patients.
• The current grading system provides more accurate risk stratification compared to historical methods.
• Updated Gleason grading facilitates better patient counseling and treatment decisions.